Dedicated to women's health and well-being

HerArticle

Sponsored By

GlaxoSmithKline's Cervical Cancer Vaccine Protects Against Five Viruses, Study Shows

July 16, 2009 - 7:56am 890 reads 0 comments

RESEARCH TRIANGLE PARK, N.C. - A study published Tuesday shows that a cervical cancer vaccine from drug giant GlaxoSmithKline (NYSE:GSK) is effective against not one but five of the most common viruses related to cancer.

Glaxo, which maintains its U.S. headquarters in RTP, paid for the study that was published in The Lancet.

The results show Cervarix is highly effective against the most common cervical cancer-causing virus types and has the potential to substantially reduce the incidence of cervical pre-cancers, cervical cancer and the associated diagnostic and surgical procedures, said professor Jorma Paavonen, from the University of Helsinki, Finland, the principal investigator of the study.

The results re-affirm confidence in vaccination as a primary preventative measure against cervical cancer when used alongside screening, he added.

GSK is seeking regulatory approval to sell Cervarix in the U.S. Cervarix is seen as a potential rival to Merck's Gardasil, which already is sold in the U.S. Cervarix produced more than $230 million in sales for GSK last year.

Add A New Comment

We value and respect the experiences of all of our HerWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Start Asking & Sharing

Add A New CommentComments

There are no comments yet. Be the first to get the conversation started.

Log in

Are you a member? Log in first to track your posts

Not a member? Join us. Membership is not required to post.

More information about formatting options

We never share email addresses with third parties. Your email address will be used to notify you of activity on your post and send you our newsletter if you choose to sign up for it.
Verify that you are a human (not a computer):
This is necessary to prevent computer programs from automatically posting spam or other irrelevant content on EmpowHer.com. Enter the characters in the box to the left (case sensitive). Do not enter spaces between the characters.
Image CAPTCHA

EmpowHer's Health Newsletter

The latest women's health news delivered to you each week

Featured Provider Discover more about the nation's top provider.

Cancer Treatment Centers of America

Cancer Treatment Centers of America

For almost 30 years, Cancer Treatment Centers of America (CTCA) has been on the leading edge of cancer treatment with its individualized, whole-person care model. With cancer hospitals in suburban Chicago, Philadelphia, Tulsa, and suburban Phoenix, CTCA continues to expand its accessibility to patients. Our cancer experts provide a full range of treatment options—including options for advanced stage cancers and complex cases—all under one roof.

HerStory View compelling videos from everyday women

Rose
Rose
SurvivHer

VIDEO - HERSTORY: Rose Shares If She Is Happy With Her CTCA Cancer Treatment

Rose explains if she is satisfied with her breast cancer treatment care at CTCA.

View this HerStory

Health News Read up-to-the-minute medical news & stories.

Study Suggests Link Between Cell Phones and Brain Tumors

TUESDAY, Oct. 13 (HealthDay News) -- The latest study focusing on a possible cell phone-brain tumor connection finds a weak potential link between the two. A review of existing research on the ...
Read more